Nikhil Lalwani - 21 Mar 2022 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani
Issuer symbol
ANIP
Transactions as of
21 Mar 2022
Net transactions value
+$199,997
Form type
4
Filing time
23 Mar 2022, 21:05:44 UTC
Previous filing
10 Sep 2021
Next filing
25 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Purchase $199,997 +7,224 +4.4% $27.69 169,650 21 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired in multiple trades at prices ranging from $26.885 to $27.8058. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.